Servier expands partnership with Google AI

International pharmaceutical group Servier has expanded its partnership with Google Cloud to accelerate the research and development (R&D) of pharmaceuticals.This expanded five-year agreement will see Servier using Google Cloud's AI offerings for R&D. Google Cloud will help Servier to analyze large amounts of medical data in real time.

"At Servier, we firmly believe that the combination of scientific innovation and advanced digital technologies, especially artificial intelligence, will enable us to bring innovative treatments to patients more quickly and more personalized solutions," said Claude Bertrand, EVP of R&D and chief scientific officer at Servier. "Our enhanced collaboration with Google Cloud gives us the opportunity to harness the full potential of AI to reach scientific conclusions more rapidly and thus increase the productivity of our R&D."

"We are both delighted and impressed by Servier's use of our AI and generative AI technology to accelerate its research and development programs," said Shweta Maniar, global director of healthcare & life sciences at Google Cloud. "Servier is moving quickly from experimentation to production, in a pragmatic way, with a clear priority given to ethics, confidentiality, and security. This collaboration will lead to new progress in the research and treatment of many diseases in the years to come - we can't wait to see what will come next."